tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BIIBBiogen

Health care · Biotechnology · Nasdaq
Compare with peers → Embed
CEO pay, fiscal year to Dec 31, 2025

Mr. Viehbacher was paid $23.6M as reported, $27.7M at the share price

Proxy (DEF 14A)
CEO pay, as reported
$23.6M
salary, bonus and awards at grant value
CEO pay, actually paid
$27.7M
awards valued at the share price
$100 in the shares became
$72
peer group: $120
CEO pay, 5 years
$126.7M
up 34% while net income fell 17%
Pay versus performance

Pay against results, year by year

Proxy, filed Apr 28, 2026
Fiscal year toCEOCEO pay (reported) CEO pay (actually paid) Other executives, average$100 becamePeer groupNet income Revenue
Dec 31, 2025Mr. Viehbacher $23.6M$27.7M $5.9M $72$120 $1.3B $9.8B
Dec 31, 2024Mr. Viehbacher $24.2M$1.3M $6.4M $62$91 $1.6B $9.0B
Dec 31, 2023Mr. Viehbacher $4.1M-$4.5M $6.3M $106$92 $1.2B $9.7B
Dec 31, 2022Mr. Viehbacher, Mr. Vounatsos $57.1M$33.5M $5.9M $113$89 $3.0B $10.3B
Dec 31, 2021Mr. Vounatsos $17.7M$15.2M $5.8M $98$99 $1.6B $11.1B

Pay versus performance table of the proxy statement (DEF 14A) filed Apr 28, 2026, as tagged by the company in XBRL. Open the proxy ↗

Next Crypto holdings →